跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Roflumilast N-oxide
首页
药物
Roflumilast N-oxide
Roflumilast N-oxide
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide
US 9649302 B2
申请人: INCOZEN THERAPEUTICS PVT LTD
优先权: 2013
CN
EP
US
7 件公开
Roflumilast for the Treatment of Diabetes Mellitus
US 2008214625 A1
申请人: KLEY HANS-PETER
优先权: 2005
CN
US
6 件公开
Roflumilast for the treatment of pulmonary hypertension
US 8648100 B2
申请人: BEUME ROLF
优先权: 2005
CN
US
3 件公开
Pharmaceutical Composition Comprising Roflumilast or the N-Oxide of Roflumilast
US 2008045572 A1
申请人: ALTANA PHARMA AG
优先权: 2004
US
Combination of HMG-COA reductase inhibitors, such as roflumilast, roflumilast-N-oxide with a phosphodiesterase 4 inhibitor, rosuvastatin, for the treatment of inflammatory pulmonary diseases
CN 102772411 A
申请人: NYCOMED GMBH
优先权: 2006
CN
Roflumilast N-oxide polymorphs and their preparation methods and pharmaceutical composition
CN 103382177 A
申请人: UNIV CHINA PHARMA
优先权: 2012
CN
Preparation method of roflumilast active metabolite
CN 103073490 A
申请人: BEIJING D VENTUREPHARM T CORP
优先权: 2012
CN
Preparation method of roflumilast N-oxide
CN 106256820 A
申请人: SICHUAN HAISCO PHARMACEUTICAL CO LTD
优先权: 2015
CN
药物
反馈